Tarsus Pharmaceuticals, Inc. Quarterly Current Ratio in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Tarsus Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q2 2021 to Q3 2024.
  • Tarsus Pharmaceuticals, Inc. Current Ratio for the quarter ending September 30, 2024 was 669 %, a 49.1% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 669 -646 -49.1% Sep 30, 2024
Q2 2024 790 -685 -46.5% Jun 30, 2024
Q1 2024 885 -795 -47.3% Mar 31, 2024
Q4 2023 1.03K -616 -37.4% Dec 31, 2023
Q3 2023 1.31K -361 -21.5% Sep 30, 2023
Q2 2023 1.48K -240 -14% Jun 30, 2023
Q1 2023 1.68K +25.9 +1.57% Mar 31, 2023
Q4 2022 1.64K -136 -7.66% Dec 31, 2022
Q3 2022 1.68K -389 -18.9% Sep 30, 2022
Q2 2022 1.72K -316 -15.5% Jun 30, 2022
Q1 2022 1.65K Mar 31, 2022
Q4 2021 1.78K Dec 31, 2021
Q3 2021 2.06K Sep 30, 2021
Q2 2021 2.03K Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.